Australian environmental testing, laboratory services, and scientific solutions company ALS (ASX:ALQ) highlighted deteriorating volumes in its geochemistry business and higher net interest costs in its fiscal first-half trading update, but its life sciences segment continues to be resilient, according to a Sept. 19 note from Jarden Research.
Commodities should adjust to further volume volatility as geochemistry sampling has been volatile during the period as Australian volumes fell 10% on already weak conditions, the investment firm said. Jarden expects the company to address this in its cost base and boost hub utilization from fiscal 2025 to fiscal 2027.
Jarden kept its overweight rating on ALS and reduced its price target to AU$14.20 from AU$14.90.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。